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Abstract
Background:  Health care practice based on research evidence requires that evidence is synthesised, and that
recommendations based on this evidence are implemented. It also requires an intermediate step: translating synthesised
evidence into practice recommendations. There is considerable literature on evidence synthesis and implementation, but
little on how guideline development groups (GDGs) produce recommendations. This is a complex process, with many
influences on communication and decision-making, e.g., the quality of evidence, methods of presentation, practical/
resource constraints, individual values, professional and scientific interests, social and psychological processes. To make
this process more transparent and potentially effective, we need to understand these influences. Psychological theories
of decision-making and social influence provide a framework for this understanding.
Objectives: This study aims to investigate the processes by which GDGs formulate recommendations, drawing on
psychological theories of decision-making and social influence. The findings will potentially inform the further evolution
of GDG methods, such as choice of members and procedures for presenting evidence, conducting discussion and
formulating recommendations.
Methods: Longitudinal observation of the meetings of three National Institute of Health and Clinical Excellence (NICE)
GDGs, one from each of acute, mental health and public health, will be tape recorded and transcribed. Interviews with
a sample of GDG members at the beginning, middle, and end of the GDG's work will be recorded and transcribed. Site
documents including relevant e-mail interchanges, GDG meeting minutes, and stakeholders' responses to the drafts of
the recommendations will be collected. Data will be selected for analysis if they refer to either evidence or
recommendations; the focus is on "hot spots", e.g., dilemmas, conflicts, and uncertainty. Data will be analysed thematically
and by content analysis, drawing on psychological theories of decision-making and social influence.
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Background
Widespread claims of evidence-based clinical practice are
premised on development of recommendations based on
research evidence. Using research evidence to inform prac-
tice requires three stages: synthesising evidence, translat-
ing evidence into recommendations, and implementing
recommendations in practice. There is considerable liter-
ature on the processes of synthesising evidence, and of
implementing recommendations, but little on how evi-
dence is translated into recommendations. The model of
guideline development adopted by the National Institute
for Health and Clinical Excellence (NICE) in the United
Kingdom involves a Guideline Development Group
(GDG) comprising academic, professional, and lay repre-
sentatives from relevant disciplines and practices. Groups
meet between three and fifteen times to consider evidence
and recommendations. Their face-to-face and e-mail dis-
cussions are informed by: Verbal and written presentation
of research evidence by systematic reviewers and health
economists as well as contextual evidence from co-opted
experts; comments on the evidence and draft recommen-
dations by stakeholders; and comments and advice by
NICE internal review teams.
Despite the stated evidence base of guideline recommen-
dations, there is little information about the relationship
between research evidence and recommendations. A
study of 15 clinical guidelines on Type 2 diabetes from 13
countries found that research evidence is not necessarily
the most powerful influence on the content of recommen-
dations [1]. The investigators found little overlap between
guidelines in the evidence used: only 18% of citations
were shared with any other guideline, and only 1%
appeared in six or more guidelines. Despite this, there was
a high degree of consensus about recommendations
about clinical care. Very different results were found in a
study of two independent expert panels formulating
appropriateness criteria for investigation of patients with
angina. Given the same evidence summary and using a
formal consensus process, the two groups showed only
moderate agreement in their recommendations, with a
two fold difference in their estimates of under-use for
investigations in some subgroups of patients (Heming-
way, et al., personal communication).
There is often no explicit framework for the conduct of the
discussion or decision-making within GDGs. There are
various possible influences on group discussion and deci-
sions, e.g., the quality of evidence, the methods of presen-
tation of the evidence, evaluation of different types of
evidence, weight given to economic evidence, practical/
resource constraints, opportunity costs, values (implica-
tions for inequalities), degree of change required by the
recommendations, professional and scientific interests,
potential direct or indirect financial interests [2,3], and
the knowledge and experience of the group members in
evidence evaluation and synthesis. Additionally, social
and psychosocial processes within small groups (e.g. sta-
tus, conformity and compliance) may influence guideline
development [4]. Several tensions within this process
have been reported: The extent to which recommenda-
tions should reflect contextual experience rather than just
research evidence; the extent to which practical con-
straints should shape recommendations; and whether
more evidence is needed to stop current practice than to
start something new. A recent study using formal consen-
sus methods for clinical guidelines found that half of
group judgments did not agree with the research evidence.
Where clinical experience and beliefs were not consistent
with research evidence, the experience and beliefs seemed
to take precedence [5].
There are calls for greater transparency about the processes
of synthesising research and other evidence and of trans-
lating these into recommendations, but how best to do
this is unclear. There are also calls for current practice to
be changed to briefer, more structured deliberations [6].
However, changing future practice should be informed by
understanding current practice.
Communication with experts in the field and subsequent
literature searches identified four studies that have ana-
lysed GDG processes. A pilot study has examined norma-
tive influences on guideline construction, although it was
unclear what were "normative influences" [7]. Pagliari
and Grimshaw analysed social interaction between mem-
bers and amount of communication according to profes-
sional status, and found more communication amongst
higher status professionals [8]. A sociological analysis of
the structure and organisation of group processes found
four domains of group reasoning: the scientific quality of
evidence, the practical basis of recommendations, politi-
cal implications of recommendations, and the quality of
the process that evaluated evidence and formulated rec-
ommendations [9,10].
The current study aims to build on this work by drawing
on psychological theories of decision-making and social
influence in describing and analysing how issues in these
areas are resolved, with a goal of identifying good practice.
It will do this across three health care settings (acute
health, mental health and public health).
Aims
To investigate the processes by which GDGs formulate
recommendations on the basis of the research evidence
they receive, using psychological theory to guide data
analysis.
The main questions to be addressed concern:Implementation Science 2007, 2:29 http://www.implementationscience.com/content/2/1/29
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1. Who? Who has most influence, demonstrates particular
approaches
2. How? What strategies are used in considering evidence
and in formulating recommendations
3. Why? What beliefs about the purpose and nature of evi-
dence and recommendations may explain these strategies
4. With what result? GDG members views about the qual-
ity of GDG process and outcome; objective quality indica-
tors of the recommendations, e.g., clarity,
comprehensibility.
Methods
Study design
A longitudinal observation study of the development of
national guideline practice recommendations, from the
first to last GDG meeting.
Participants
The first NICE GDG to start from November 2006 in each
of three areas of health care, acute health, mental health
and public health, will be selected. The GDGs participat-
ing in the study are not specified in order to protect ano-
nymity of the members.
Data collection
Data will be collected from several sources:
Meetings
Meetings of GDGs and their topic group will be tape
recorded and transcribed. Using an ethnographic
approach, a researcher will attend meetings, take field-
notes, and make observations. Members will be asked to
introduce themselves by name and role at the beginning
of each meeting to assist in their identification. The
researcher will position herself in a place that is as unob-
trusive as possible, but that will allow identification of
speakers and a view of members' facial expressions. Not
all meeting recordings will be transcribed and analysed. A
pre-validated process will be used to identify the key
exchanges and interactions relating to recommendations
and evidence. Data from the pilot study is being used to
develop criteria for this process.
Site documents include relevant e-mail interchanges,
GDG meeting minutes, and stakeholders' responses to
draft recommendations. Given the large number of e-
mails that each GDG may generate, the research group
will use the pilot study to develop a "key word" search
approach to filter the site documents on the basis of their
relevance to evidence and recommendations.
Individual interviews
Following the first GDG meeting, the researcher will select
a purposive sample for interviews from the different con-
stituencies in the group (i.e., service providers, academics,
practitioners, service users, systematic reviewers, NICE
project team and chair). A selection of group members,
representing different levels of involvement, will be inter-
viewed at the beginning, middle, and end of the GDG
process. Higher order interview questions have been
developed to investigate GDG members' perceptions of
the factors influencing their thinking and decisions about
recommendations (additional file 1). These higher order
questions will be mapped to specific incidences from each
guideline meeting (identified by the researcher) in order
to ensure the interviews are specific and focussed. Inter-
views will be audiotaped and transcribed.
Group interviews
The findings from the GDG discussions and interviews
will be presented to GDGs for their comments to inform
the face "validity" of the findings as well as any implica-
tions of the findings for future practice. The findings will
be presented and responses sought first by e-mail to GDG
members, followed by a discussion with the GDG as a
whole. This will allow less vocal GDG members to input
their views, while also enabling group interaction.
Stakeholders' comments
These are collected routinely and presented to the GDG.
Contextual influences may occur during the study period,
e.g., high profile media or scientific publications. If these
are discussed within the context of any GDG, they will be
highlighted in the analysis.
Piloting
The above procedures – gaining consent, the GDG obser-
vation, transcript analysis, collection and use of e-mail
data – were piloted in September 2006 on a GDG that was
considered by NICE members of the study steering group
to be fairly representative.
Data analysis
Data will be selected if they refer to either evidence or rec-
ommendations; the focus will be on "hot spots", e.g.,
dilemmas, conflicts, and uncertainty. Selected transcript
excerpts will be analysed thematically and by content
analysis. The analysis of the transcripts and other data will
draw upon a number of different theories, including
group decision-making [11,12] and communication/per-
suasion [13] theories. In consensual group decision-mak-
ing (such as that occurring in NICE GDGs), it is assumed
that there are background factors at play in the group's
decision-making processes beyond the expression of mere
individual preferences. These background factors includeImplementation Science 2007, 2:29 http://www.implementationscience.com/content/2/1/29
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cognitive and affective components that are shared among
the group during the decision-making process [11]. Such
components include majority/plurality processes (the
degree to which members' preferences about information
and evidence are shared socially), group polarisation
(processes by which extremes in an individual's prefer-
ence will be exaggerated when the group's preferences are
combined), procedural manipulation (the manipulation
of group preferences presenting information in a specific
order or manner), and the common knowledge effect
(where shared information is more likely to be discussed
within a group than unshared information). Specific fea-
tures of communication and the process of persuasion
may influence how GDGs translate evidence into recom-
mendations. The elaboration likelihood model of persua-
sion [13] suggests that when individual group members
are subject to persuasive messages from others in their
group with specific agendas, their ability and desire to
cognitively elaborate on that message may influence the
process and outcomes of decisions about the evidence.
In data analyses, discrepancies between reported and
observed processes will be highlighted, as will any areas of
tension or difficulty. Case studies will be systematically
identified and analysed within the development process,
e.g., uncontroversial translation of evidence into recom-
mendations; lack of evidence for a practice but recom-
mendation for it; clear evidence but no associated
recommendation made; mixed evidence and no recom-
mendation; and mixed evidence and recommendation
made.
A variety of published GDG recommendations will be
used to develop a reliable measure of recommendation
clarity, e.g., readability, perceived comprehensibility, spe-
cificity and avoidance of ambiguity, and building on prior
research [14,15].
Deliverables
The primary deliverable for the study will be a set of rec-
ommendations, including the composition of GDGs, the
presentation of evidence, and discussion of recommenda-
tions to aid transparent decision-making and reporting in
GDGs.
Data management
A signed confidentiality agreement between the research-
ers, NICE, and the GDG chairs specify which GDG docu-
ments will be accessed, where they will be kept and
reviewed, storage/disclosure, and access to data. Data will
be anonymised as much as possible, and individuals will
be given the opportunity to see draft reports to satisfy
themselves about anonymity.
Ethics
The study received ethics approval from the Research Eth-
ics Committee of the UCL Psychology Department (ref:
0819/001). A study information sheet (additional file 2)
will be provided to all GDG members before their first
GDG meeting, and informed consent (additional file 3)
will be sought for use of the following data: transcripts of
GDG discussions, site documents (minutes arising out of
the GDG meetings, e-mail exchanges about GDG business
between GDG members, and draft versions of the recom-
mendations), interviews with GDG members, and feed-
back focus groups of GDG members to comment on
findings from the transcripts, e-mails, and interviews.
Comments from non-consenting GDG members will not
be transcribed.
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